Jeffrey Jonker
Directeur Général chez Belharra Therapeutics, Inc.
Fortune : - $ au 31/05/2023
Profil
Jeffrey Jonker is currently the Chief Executive Officer at Regeneration NewCo, Inc. and the Chief Executive Officer & Director at Belharra Therapeutics, Inc. He is also serving as the Treasurer & Director at California Life Sciences Association since 2019.
Previously, he held positions such as President, Chief Executive Officer & Director at Ambys Medicines, Inc. from 2018 to 2020, Director-Business Development at Genentech, Inc. from 2003 to 2009, Independent Director at Metacrine, Inc. from 2021 to 2023, VP-Business Development & Corporate Strategy at Gloucester Pharmaceuticals, Inc. from 2009 to 2010, Chief Business Officer at Satori Pharmaceuticals, Inc. from 2010 to 2013, and President at NGM Biopharmaceuticals, Inc. from 2014 to 2018.
He also worked as a Member-Technology Transactions Group at Wilson Sonsini Goodrich & Rosati PC and as a Senior VP-Corporate & Business Development at Innoviva, Inc. Additionally, he served as the Executive Vice President & General Manager at Hangover Joe's Holding Corp.
in 2013 and as the Senior VP-Corporate & Business Development at Theravance Biopharma, Inc. from 2013 to 2014.
Mr. Jonker completed his undergraduate studies at Claremont McKenna College and pursued graduate studies at the University of St. Andrews and Columbia Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
METACRINE INC
-.--% | 03/02/2023 | 0 ( -.--% ) | - $ | 31/05/2023 |
Postes actifs de Jeffrey Jonker
| Sociétés | Poste | Début |
|---|---|---|
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Directeur/Membre du Conseil | - |
Regeneration NewCo, Inc.
 Regeneration NewCo, Inc. Financial ConglomeratesFinance Regeneration NewCo, Inc. operates as a development stage company. The company is headquartered in South San Francisco, CA. | Directeur Général | - |
Belharra Therapeutics, Inc.
 Belharra Therapeutics, Inc. Medical/Nursing ServicesHealth Services Belharra Therapeutics, Inc. is a drug discovery company that utilizes a unique photoaffinity-based chemoproteomics platform to identify novel small molecule drug candidates for previously difficult-to-treat diseases and conditions. The company is based in San Diego, CA, with its primary lab and offices located in the area. Belharra's proprietary discovery engine allows for the identification of small molecule starting points for drug development on any protein, in any conformational state, and in any cell type. The company was founded in 2021 by John Teijaro, Christopher G. Parker, Stuart L. Schreiber, and Benjamin F. Cravatt, and has since been led by CEO Jeffrey Jonker. | Directeur Général | 01/09/2021 |
Anciens postes connus de Jeffrey Jonker
| Sociétés | Poste | Fin |
|---|---|---|
| METACRINE, INC. | Directeur/Membre du Conseil | 23/03/2023 |
Ambys Medicines, Inc.
 Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Ambys Medicines, Inc. develops regenerative medicine therapies for serious liver diseases. The company was founded by Martin Burke, Markus Grompe, Juan Carlos Izpisua Belmonte and Holger Willenbring and is headquartered in South San Francisco, CA. | Directeur Général | 01/06/2020 |
| NGM BIOPHARMACEUTICALS, INC. | President | 01/09/2018 |
| THERAVANCE BIOPHARMA, INC. | Corporate Officer/Principal | 01/01/2014 |
| HANGOVER JOE'S HOLDING CORP | Corporate Officer/Principal | 31/10/2013 |
Formation de Jeffrey Jonker
| Claremont McKenna College | Undergraduate Degree |
| University of St. Andrews | Graduate Degree |
| Columbia Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| INNOVIVA, INC. | Health Technology |
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Gloucester Pharmaceuticals, Inc.
 Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | Health Technology |
Satori Pharmaceuticals, Inc.
 Satori Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Satori Pharmaceuticals, Inc. developed therapeutics for alzheimer's disease. The firm's drug candidates selectively modulated gamma secretase, the enzyme generating the neurotoxic peptides that form amyloid beta plaques the signature of this debilitated disease. The company was founded by Mark A. Findeis and Dennis J. Selkoe in 2005 and was headquartered in Cambridge, MA. | Health Technology |
Wilson Sonsini Goodrich & Rosati PC
 Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Wilson Sonsini Goodrich & Rosati PC provides legal services. Its services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Commercial Services |
Hangover Joe's Holding Corp.
 Hangover Joe's Holding Corp. Beverages: Non-AlcoholicConsumer Non-Durables Hangover Joe's Holding Corp. engages in the production of a drunkenness recovery product. It sells an all-natural two-ounce beverage shot for the symptoms associated with alcohol induced hangovers. The company was founded by Michael Jaynes and Shawn Adamson on December 1, 2005 and is headquartered in Highlands Ranch, CO. | Consumer Non-Durables |
Ambys Medicines, Inc.
Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Ambys Medicines, Inc. develops regenerative medicine therapies for serious liver diseases. The company was founded by Martin Burke, Markus Grompe, Juan Carlos Izpisua Belmonte and Holger Willenbring and is headquartered in South San Francisco, CA. | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Commercial Services |
Regeneration NewCo, Inc.
Regeneration NewCo, Inc. Financial ConglomeratesFinance Regeneration NewCo, Inc. operates as a development stage company. The company is headquartered in South San Francisco, CA. | Finance |
Belharra Therapeutics, Inc.
Belharra Therapeutics, Inc. Medical/Nursing ServicesHealth Services Belharra Therapeutics, Inc. is a drug discovery company that utilizes a unique photoaffinity-based chemoproteomics platform to identify novel small molecule drug candidates for previously difficult-to-treat diseases and conditions. The company is based in San Diego, CA, with its primary lab and offices located in the area. Belharra's proprietary discovery engine allows for the identification of small molecule starting points for drug development on any protein, in any conformational state, and in any cell type. The company was founded in 2021 by John Teijaro, Christopher G. Parker, Stuart L. Schreiber, and Benjamin F. Cravatt, and has since been led by CEO Jeffrey Jonker. | Health Services |
| Metacrine, Inc. |
